The ethics of CRISPR gene editing has emerged as a pivotal discussion in contemporary bioethics, particularly in light of its potential to revolutionize treatments, such as those for sickle cell disease.This groundbreaking CRISPR technology provides scientists the unprecedented ability to modify genetic codes, raising significant questions about the implications of altering human DNA.